Oregovomab – OvaRex; Mab B43.13; CA125 tumor antigen monoclonal antibody -- Product Record

CA125 Mab

    Nomenclature:
      OvaRex [TR]
      Oregovomab [USAN INN]
      immunoglobulin G1, anti-(human CA125 (carbohydrate antigen)) (mouse monoclonal B43.13gamma1-chain), disulfide with mouse monoclonal B43.13kappa-chain, dimer [CAS]
      213327-37-8 [CAS RN]
      Antibody-based ImmunoTherapy (AIT) [SY]
      B43.13 [SY]
      MAb B43.13 [SY]
      MAb-B43.13 [SY]
      ATCC PTA-1883 [ATCC]

    FDA Class:  Biologic BLA

Index Terms:

  • Product Class Index:
      biopharmaceutical products
      murine (mouse) materials used
  • Biological Index:
      antibodies (see also immune globulins; monoclonal antibodies)
      ATCC HB8832
      autologous cells, human
      C7F7 monoclonal antibody
      murine (mouse) hybridoma cells
      murine feeder cells
      phosphorothioates
      tumor necrosis factor-2 receptor (TNFR2)
  • Chemical Index:
      antibodies (see also immune globulins; monoclonal antibodies)
      leukocyte removal
      phosphorothioates
      U.S. Standard Rabies Vaccine
      U.S. Standard Rabies Vaccine
  • Source/Host/Expression System: Murine myeloma mamrodmurmyel
  • Regulatory/Status Index:
      apheresis (hemapheresis)
      North American coral snake
      orphan status
      EU000 Not yet/Never filed with EU
      SM200 Not Available/Not Marketed
      US000 never filed/no plans
      EM999 Not Available/Not Marketed in EU